European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

V A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment

Descripción del proyecto

Incorporación de la informática a los cuidados del accidente cerebrovascular

El uso del aprendizaje automático (AA) y la inteligencia artificial (IA) va en aumento en el campo de la medicina, lo que ayuda al diagnóstico y la toma de decisiones de tratamiento. Tal es el caso de la atención a los accidentes cerebrovasculares. Un sistema informático de apoyo clínico (CDSS, por sus siglas en inglés) puede ir más allá del actual estado de la técnica clínica y encontrar relaciones complejas y no lineales entre una multitud de variables de pronóstico. El equipo del proyecto VALIDATE, financiado con fondos europeos, desarrollará un CDSS para el tratamiento de pacientes que han sufrido un accidente cerebrovascular. A partir de los datos disponibles y aprovechando las oportunidades tecnológicas actuales en el campo de la IA, desarrollará soluciones de IA fiables destinadas a mejorar la supervivencia y la calidad de vida de estos pacientes. Las decisiones de tratamiento tomadas mediante el análisis de datos basado en la IA serán más seguras, rápidas y precisas.

Objetivo

Based on previously developed models and an existing prototype of a clinical decision support system (patent pending), we set out in this project to further develop, test, and validate this clinical decision support for the treatment stratification of acute stroke patients to improve patient outcome. Machine learning (ML)-enabled Artificial intelligence (AI) methods are increasingly adopted in the medical field. Implementing ML-based CDSSs have the potential to be go beyond the current clinical state-of-the-art as AI excels at finding complex and non-linear relationships across a multitude of prognostic variables. AI also has the promise to combine different modalities, such as imaging and clinical values, leading to powerful stratification tools accounting for a multitude of patient sub-populations. Our consortium combines excellence in technical and medical machine learning development with the clinical expertise of three leading stroke hospital partners. Additionally, our consortium benefits from the special expertise in the development of trustworthy AI, software design, and the translation of AI models to the clinical setting with focus on the regulatory process. By leveraging the available medical data and exploiting technological opportunities in the field of AI, and developing and validating trustworthy AI solutions to be implemented in the clinical workflow we are seeking to surpass the clinical state-of-the-art by making a significant and sustainable impact on the treatment of acute stroke that will improve patient survival, outcome and quality of life. The results of our work will serve as a pathway for future projects and we will make our experiences public in the form of standard operating procedures (SOPs) in the areas of development, testing, validation, and regulatory processes.

Coordinador

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Aportación neta de la UEn
€ 1 220 625,00
Dirección
Chariteplatz 1
10117 Berlin
Alemania

Ver en el mapa

Región
Berlin Berlin Berlin
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 1 220 625,00

Participantes (9)